Results 71 to 80 of about 3,048 (204)

Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer. [PDF]

, 2014
Well-established associations between reproductive characteristics and epithelial ovarian cancer (EOC) support an involvement of sex steroid hormones in the etiology of EOC.
Adami, Allen, Anne Zeleniuch-Jacquotte, Auersperg, Bodmer, Chen, Cramer, Edmondson, Eero Pukkala, Eva Lundin, Fathalla, Hans-Åke Lakso, Helena Schock, Heljä-Marja Surcel, Helzlsouer, Kjell Grankvist, Kurman, Kurman, Lukanova, Lukanova, Lukanova, Mall-Haefeli, Matti Lehtinen, Morch, O'Leary, Paolo Toniolo, Pearce, Prat, Rannevik, Renée Turzanski Fortner, Riman, Rinaldi, Risch, Rudolf Kaaks, Schildkraut, Syed, Thomas, Tsilidis, Whitehead, Whiteman, Whittmore, Wiegratz   +41 more
core   +1 more source

The value of automated follicle volume measurements in IVF/ICSI [PDF]

, 2014
Background/Aims: The objective of this literature study is to investigate the place of recent software technology sonography-based automated volume count (SonoAVC) for the automatic measurement of follicular volumes in IVF/ICSI.
Bracke, Victoria, De Sutter, Petra, Vandekerckhove, Frank   +2 more
core   +2 more sources

Association Between Weight‐Adjusted Waist Index (WWI) and Bone Mineral Density in Postmenopausal Women: A Cross‐Sectional Analysis of NHANES Data

International Journal of Endocrinology, Volume 2025, Issue 1, 2025.
Background: Osteoporosis represents a critical public health challenge, particularly among postmenopausal women, characterized by reduced bone mineral density (BMD) and increased fracture risk. Traditional obesity metrics such as body mass index (BMI) and waist circumference (WC) have limitations in assessing bone health due to their inability to ...
Qifeng Jing, Yan Tan, Suraiya Saleem
wiley   +1 more source

Case Report: Borderline tumor and primary peritoneal carcinoma - a rare synchronism [version 2; peer review: 2 approved]

F1000Research, 2019
Ovarian borderline serous tumors present with peritoneal involvement in 20% of cases, either as non-invasive or invasive implants, the latter also known as extraovarian low-grade serous carcinoma.
Mariana Rei, Sofia Raposo, Paulo Figueiredo, Rita Sousa, Luís Sá   +4 more
doaj   +1 more source

A case of ovarian carcinosarcoma with germline BRCA2 pathogenic variant

Journal of Obstetrics and Gynaecology Research, Volume 50, Issue 12, Page 2362-2366, December 2024.
Abstract Ovarian carcinosarcoma in hereditary breast and ovarian cancer syndrome is rare. A 43‐year‐old woman with a family history of prostate and uterine or ovarian cancer had an 8‐cm mass in the right ovary. Although computed tomography suggested peritoneal dissemination to the Douglas pouch, she wanted to preserve her fertility; therefore, she ...
Kaori Yoriki, Yuko Izumi, Yosuke Tarumi, Hiroyuki Okimura, Eiko Maeda, Taisuke Mori   +5 more
wiley   +1 more source

Polycystic ovary syndrome [PDF]

, 2004
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide.
A Corbould, A Corbould, A Dokras, A Dunaif, A Dunaif, A Dunaif, A Dunaif, A Gambineri, AA Deeks, AA Deeks, AD Coviello, AE Joham, AJ Krentz, AM Goss, AY Chang, B Banaszewska, B Dilbaz, BA Gower, BA Swiglo, BC Fauser, BC Fauser, BO Yildiz, BO Yildiz, BO Yildiz, BO Yildiz, BO Yildiz, BW Donesky, C Battaglia, C Farquhar, C Formuso, C Kitzinger, C Siristatidis, C Villarroel, CA McHorney, CB Book, Centers for Disease Control and Prevention (CDC), CJ Carlson, CK Welt, CL Harrison, CL Harrison, CM Boomsma, CM Burt Solorzano, CM DeUgarte, CN Bairey Merz, CR McCartney, D Cibula, D Lizneva, D Rosenbaum, D Skubleny, DA Dumesic, DA Dumesic, DA Ehrmann, DM Liu, DS Kiddy, DW Polson, E Carmina, E Carmina, E Carmina, E Carmina, E Carmina, E Carvalho, E Dahlgren, E Diamanti-Kandarakis, E Diamanti-Kandarakis, E Diamanti-Kandarakis, E Lerchbaum, E Vanky, EJ van Zuuren, EO Talbott, F Alvarez-Blasco, F Fanelli, F Ramezani Tehrani, FJ Broekmans, FL Teixeira Filho, FR Day, FR Tehrani, G Chazenbalk, G Conway, G Daskalopoulos, G Guyatt, G Kosova, G Ladson, GG Gosman, GL Fraser, H Abu Hashim, H Mani, HF Escobar-Morreale, HJ Teede, HJ Teede, I Ek, I Souter, J Du, J Laitinen, J Schmidt, J Sun, J Zawadzki, JA Balfour, JA Visser, JA Visser, JE Nestler, JE Nestler, JL Cresswell, JM McAllister, JM Vink, JP Baillargeon, JS Laven, KA Townsend, KG Ewens, KK Naka, KK Roessler, KY Cha, L Barnard, L Cronin, L Cui, L Cui, L Gao, L Ibanez, L Ibanez, L Ibanez, L Manneras-Holm, L Moran, L Sterling, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Moran, LJ Webber, LO Tso, M Api, M Eriksen, M Harris-Glocker, M Hudecova, M Kahsar-Miller, M Luque-Ramirez, M Luque-Ramirez, M Maliqueo, M Rajkhowa, M Wiksten-Almstromer, MA Sagle, MB Khomami, ME Gibson-Helm, MG Hayes, MH van Hooff, MJ Nahuis, MJ Solnik, ML Pan, ML Walls, MM Zain, MR Jones, N Cinar, N Cinar, N Lass, N Naderpoor, N Roos, NF Goodman, NK Stepto, NM Daan, NM O'Meara, O Koulouri, O Valkenburg, P Moghetti, PO Dale, Q Du, R Azziz, R Azziz, R Azziz, R Azziz, R Azziz, R Azziz, R Hart, R Homburg, R Khera, R Mathur, R Pasquali, R Saxena, R Shroff, RA DeFronzo, RC Christian, RJ Norman, RL Thomson, RN Bergman, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, RS Legro, RS Legro, RS Legro, RS Legro, RS Legro, S Catteau-Jonard, S Elsenbruch, S Hahn, S Iftikhar, S Mahabeer, S Palomba, S Venturoli, S Wild, S Wild, S Zhao, SA Anderson, SA Stubbs, SE Recabarren, SM Veltman-Verhu lst, SS Lim, ST Bird, T Meas, T Sir-Petermann, T Sir-Petermann, T Tang, T Tang, Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, TP Ciaraldi, TP Ciaraldi, TP Ciaraldi, TP Ciaraldi, TY Chuang, U Ezeh, U Shim, V Padmanabhan, WT Garvey, X Cai, XJ Li, XZ Jia, Y Li, Y Shi, Y Shi, YH Chen, YV Louwers, YY Zhang, ZJ Chen   +230 more
core   +1 more source

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary

The Journal of Pathology: Clinical Research, Volume 10, Issue 6, November 2024.
Abstract Currently, the available literature provides insufficient support to differentiate between primary ovarian neuroendocrine tumors (PON) and neuroendocrine ovarian metastases (NOM) in patients. For this reason, patients with a well‐differentiated ovarian neuroendocrine tumor (NET) were identified through electronic patient records and a ...
Merijn CF Mulders, Anna Vera D Verschuur, Quido G de Lussanet de la Sablonière, Eva Maria Roes, Christoph Geisenberger, Lodewijk AA Brosens, Wouter W de Herder, Marie‐Louise F van Velthuysen, Johannes Hofland   +8 more
wiley   +1 more source

Primary ovarian malignant melanoma [PDF]

Vojnosanitetski Pregled, 2010
Background. Primary ovarian malignant melanoma is extremely rare. It usually appears in the wall of a dermoid cyst or is associated with another teratomatous component.
Kostov Miloš, Vukomanović-Đurđević Biserka, Nenadić Dane, Pavlović Miloš   +3 more
doaj   +1 more source

Targeting KRAS in gynecological malignancies

The FASEB Journal, Volume 38, Issue 19, 15 October 2024.
This review investigates the role of the KRAS pathway in gynecological malignancies, specifically cervical cancer, endometrial cancer, and ovarian cancer. It also explores therapeutic remedies targeting KRAS and its upstream/downstream pathway molecules for these cancers.
Yuanyuan Peng, Qing Yang
wiley   +1 more source

Solid pseudopapillary neoplasm of the ovary with metastases to the omentum and regional lymph nodes

Indian Journal of Pathology and Microbiology, 2016
Extrapancreatic solid pseudopapillary neoplasms (SPNs) are rare tumors, which bear morphological, immunohistochemical, and molecular features similar to those of pancreatic counterparts. SPN occurs primarily in adolescent girls and young women.
Gaurav Pratap Singh Gahlot, Asit Ranjan Mridha, Mukund Sable, Mehar Chand Sharma, Raja Pramanik, Lalit Kumar   +5 more
doaj   +1 more source